COSCIENS Biopharma Inc. (TSX:CSCI)

COSCIENS Biopharma Revenue

COSCIENS Biopharma had revenue of $3.14M USD in the quarter ending June 30, 2026, with 30.04% growth. This brings the company's total for the last twelve months to $8.28M, down -12.31% year-over-year. In the year 2025, COSCIENS Biopharma had annual revenue of $7.50M, down -21.79%. That makes COSCIENS Biopharma the 37,905th largest company in the world by revenue and 686th in Canada.

• Revenue (ttm): $8.28M
• Revenue Growth: -12.31%
• P/S Ratio: 0.69
• Revenue / Employee: $295.71K
• Employees: 28
• Market Cap: 8.60M CAD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart

• Active Ingredient 7.04M 93.9%
• Biopharmaceutical 461.00K 6.1%

By Geography

Chart

• United States 4.60M 61.4%
• Germany 2.38M 31.7%
• United Kingdom 457.00K 6.1%
• Other 59.00K 0.8%

Fiscal year ended Dec 31, 2025 See the full COSCIENS Biopharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.50M	-2.09M	-21.79%
Dec 31, 2024	9.59M	2.44M	34.22%
Dec 31, 2023	7.14M	-7.43M	-50.98%
Dec 31, 2022	14.57M	9.31M	177.03%
Dec 31, 2021	5.26M	1.61M	44.03%
Dec 31, 2020	3.65M	3.12M	586.47%
Dec 31, 2019	532.00K	-26.35M	-98.02%
Dec 31, 2018	26.88M	25.96M	2,812.35%
Dec 31, 2017	923.00K	12.00K	1.32%
Dec 31, 2016	911.00K	366.00K	67.16%
Dec 31, 2015	545.00K	534.00K	4,854.55%
Dec 31, 2014	11.00K	-6.16M	-99.82%
Dec 31, 2013	6.18M	4.12M	200.78%
Dec 31, 2012	2.05M	-2.65M	-56.37%
Dec 31, 2011	4.71M	-23.00M	-83.02%
Dec 31, 2010	27.70M	-35.53M	-56.19%
Dec 31, 2009	63.24M	24.76M	64.35%
Dec 31, 2008	38.48M	-3.59M	-8.53%
Dec 31, 2007	42.07M	3.27M	8.43%
Dec 31, 2006	38.80M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error